NAMA CRO

NAMA CRO is a leading research services provider dedicated to accelerating the development of new treatments and products. Established in 2023 as a Saudi CRO and expanding regionally in 2024, NAMA CRO specializes in clinical trials management and bioequivalence studies.

NAMA CRO partners with pharmaceutical, biotechnology, and medical device companies, offering comprehensive services in the planning, execution, and monitoring of clinical trials. With a strong focus on navigating complex regulatory requirements, NAMA CRO ensures the safety and efficacy of client products, playing a vital role in reducing time-to-market and optimizing costs. The primary address for NAMA CRO is in Riyadh, SA.

At NAMA CRO, a commitment to quality, compliance, and efficiency forms the core of their services. NAMA CRO continues to enhance its capabilities and expand its reach to serve its clients better. We invite the manager of NAMA CRO to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional services.